FDA recall D-0127-2024
Teva Pharmaceuticals USA, Inc · Class III · drug
Product
Testosterone Gel, 1.62% CIII (Alcohol 80% v/v), packaged in 30 unit-dose packets per carton, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0591-2926-30
Reason for recall
OOS for viscosity
Distribution
USA nationwide
Key facts
- Status
- Terminated
- Initiation date
- 2023-11-10
- Report date
- 2023-12-06
- Termination date
- 2024-06-03
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Parsippany, NJ, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0127-2024